Brazilian healthtech firm Nilo has successfully secured an additional $2.9 million to complete its Series A funding round, bringing the total capital raised to over $13.5 million since 2022. The investment was led by Citrino Ventures, the corporate venture capital arm of Totvs, and 14B, a new fund from Rodrigo Baer. This strategic infusion of capital is set to accelerate Nilo's transformation into an AI-native company, enhancing its software solutions for the healthcare industry.
A Strategic Pivot to Artificial Intelligence
Nilo is repositioning itself from a software provider that digitizes analog processes to a company that leverages artificial intelligence to provide meaningful context. CEO Isadora Kimura explained that the goal is to offer deeper insights into patient care to help clients generate greater value. This evolution marks a significant shift in the company's core strategy, focusing on intelligent automation over simple digital replacement.
The company is now offering AI-powered agents designed to manage patient interactions and administrative processes for hospitals, clinics, and health operators. These agents handle tasks such as triage, scheduling, and patient routing through white-label solutions integrated into platforms like WhatsApp. This functionality is built upon a rich database of patient engagement data accumulated over several years, enabling more effective and personalized communication.
A primary objective of this technology is to free medical professionals from time-consuming operational duties, allowing them to concentrate on clinical care. A beta implementation at the prestigious Hospital Israelita Albert Einstein has already demonstrated significant success, enabling the institution to manage a higher volume of patients without expanding its team. This highlights the technology's potential to improve efficiency and patient outcomes simultaneously.
Fostering an Internal AI-Driven Culture
In a move that reflects its external product strategy, Nilo is also directing the new funds toward intensifying the adoption of AI within its own operations. Co-founder and CFO Victor Marcondes emphasized that the company is committed to practicing what it preaches by building a deeply integrated AI culture. This internal focus is designed to boost productivity and foster continuous innovation without necessitating a proportional increase in headcount.
This commitment is evident across various departments, where teams are actively building their own AI tools to streamline workflows. For instance, the engineering team is using AI to re-architect systems in a fraction of the usual time, while the HR department has deployed an autonomous agent on Slack to answer employee queries. These practical applications demonstrate a company-wide mandate to become AI creators, not just users.
Marcondes believes this philosophy is crucial, stating that the product sold to clients must reflect the way the company operates internally. By empowering every employee, from marketing to finance, to build with AI, Nilo is creating a powerful feedback loop between its internal capabilities and its market offerings. This approach ensures that its solutions are both technologically advanced and grounded in practical, real-world application.
Growth Trajectory and Market Position
Originally founded during the pandemic as a digital clinic, Nilo pivoted in 2021 to a SaaS model providing CRM solutions to major healthcare players. The company has since built an impressive client roster of approximately 60 organizations, including industry leaders like Unimed, Bradesco, and Grupo Materdei. This established client base provides a solid foundation for launching its new AI-driven services.
With the fresh capital, Nilo has set ambitious goals for the near future, aiming to double or triple its revenue within the year. The strategy involves upselling its new AI agents to its existing SaaS customers while also expanding its client base by 25%. Furthermore, the company is on track to achieve breakeven for the first time in the coming months, signaling a new phase of sustainable growth.
This latest funding round marks a pivotal moment for Nilo, solidifying its transition into a key player in AI-powered healthcare technology. By championing the use of artificial intelligence both in its products and its internal culture, the company is well-positioned to drive significant efficiency gains and improve patient care. Nilo's strategic direction and strong market traction underscore its potential to reshape the healthcare landscape in Brazil and beyond.